|
1
|
Chang TP and Rangan C: Iron poisoning: a
literature-based review of epidemiology, diagnosis, and management.
Pediatr Emerg Care. 27:978–985. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mills KC and Curry SC: Acute iron
poisoning. Emerg Med Clin North Am. 12:397–413. 1994.
|
|
3
|
Elg M, Gustafsson D and Carlsson S:
Antithrombotic effects and bleeding time of thrombin inhibitors and
warfarin in the rat. Thromb Res. 94:187–197. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Augustus F, Barnard P and Guyot A: New
Universal Cyclopedia: A Scientific and Popular Treasury of Useful
Knowledge. 2. 1st edition. A. J. Johnson & Co; New York: pp.
821881
|
|
5
|
Eckly A, Hechler B, Freund M, et al:
Mechanisms underlying FeCl3-induced arterial thrombosis.
J Thromb Haemost. 779–789. 2011.
|
|
6
|
Woollard KJ, Sturgeon S, Chin-Dusting JP,
Salem HH and Jackson SP: Erythrocyte hemolysis and hemoglobin
oxidation promote ferric chloride-induced vascular injury. J Biol
Chem. 284:13110–13118. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
O’Mara NB: Anemia in patients with chronic
kidney disease. Diab Spectr. 21:12–19. 2008.
|
|
8
|
Undas A, Kolarz M, Kopec G and Tracz W:
Altered fibrin clot properties in patients on long-term
haemodialysis: relation to cardiovascular mortality. Nephrol Dial
Transplant. 23:2010–2015. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Esposito BP, Breuer W, Slotki I and
Cabantchik ZI: Labile iron in parenteral iron formulations and its
potential for generating plasma nontransferrin-bound iron in
dialysis patients. Eur J Clin Invest. 32(Suppl 1): 42–49. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lipinski B and Pretorius E: Novel pathway
of ironinduced blood coagulation: implications for diabetes
mellitus and its complications. Pol Arch Med Wewn. 122:115–122.
2012.PubMed/NCBI
|
|
11
|
Chlorek żelaza(III). Wikipedia, 2013.
http://pl.wikipedia.org/wiki/Chlorek_%C5%BCelaza%28III%29.
Wikipedia; 2013, (In Polish).
|
|
12
|
Feng W and Nansheng D: Photochemistry of
hydrolytic iron (III) species and photoinduced degradation of
organic compounds. A minireview. Chemosphere. 41:1137–1147. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Evans PA, Hawkins K, Lawrence M, Barrow
MS, Williams PR and Williams RL: Studies of whole blood coagulation
by oscillatory shear, thromboelastography and free oscillation
rheometry. Clin Hemorheol Microcirc. 38:267–277. 2008.PubMed/NCBI
|
|
14
|
Gallimore MJ, Harris SL, Tappenden KA,
Winter M and Jones DW: Urokinase induced fibrinolysis in
thromboelastography: a model for studying fibrinolysis and
coagulation in whole blood. J Thromb Haemost. 3:2506–2513. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Carr ME Jr, Krishnamurti C and Alving BM:
Effect of plasminogen activator inhibitor-1 on tissue-type
plasminogen activator-induced fibrinolysis. Thromb Haemost.
67:106–110. 1992.PubMed/NCBI
|
|
16
|
Jankun J, Aleem AM, Selman SH, et al:
Highly stable plasminogen activator inhibitor type one (VLHL PAI-1)
protects fibrin clots from tissue plasminogen activator-mediated
fibrinolysis. Int J Mol Med. 20:683–687. 2007.
|
|
17
|
Jankun J, Aleem AM, Selman SH, Basrur V
and Skrzypczak-Jankun E: VLHL plasminogen activator inhibitor
spontaneously reactivates from the latent to active form. Int J Mol
Med. 23:57–63. 2009.PubMed/NCBI
|
|
18
|
Jankun J, Keck R, Selman SH and
Skrzypczak-Jankun E: Systemic or topical application of plasminogen
activator inhibitor with extended half-life (VLHL PAI-1) reduces
bleeding time and total blood loss. Int J Mol Med. 26:501–504.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jankun J, Selman SH, Keck RW,
Lysiak-Szydlowska W and Skrzypczak-Jankun E: Very long half-life
plasminogen activator inhibitor type 1 reduces bleeding in a mouse
model. BJU Int. 105:1469–1476. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jankun J, Skotnicka M, Lysiak-Szydlowska
W, Al-Senaidy A and Skrzypczak-Jankun E: Diverse inhibition of
plasminogen activator inhibitor type 1 by theaflavins of black tea.
Int J Mol Med. 27:525–529. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jankun J, Skrzypczak-Jankun E and Lipinski
B: Complex function of magnesium in blood clot formation and lysis.
Cent Eur J Immunol. 38:149–153. 2013. View Article : Google Scholar
|
|
22
|
Nelsestuen GL, Broderius M and Martin G:
Role of gamma-carboxyglutamic acid. Cation specificity of
prothrombin and factor X-phospholipid binding. J Biol Chem.
251:6886–6893. 1976.PubMed/NCBI
|
|
23
|
Soriano-Garcia M, Padmanabhan K, de Vos AM
and Tulinsky A: The Ca2+ ion and membrane binding
structure of the Gla domain of Ca-prothrombin fragment 1.
Biochemistry. 31:2554–2566. 1992.
|
|
24
|
Urano T, Ihara H, Suzuki Y, Takada Y and
Takada A: Coagulation-associated enhancement of fibrinolytic
activity via a neutralization of PAI-1 activity. Semin Thromb
Hemost. 26:39–42. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Urano T, Ihara H, Takada Y, Nagai N and
Takada A: The inhibition of human factor Xa by plasminogen
activator inhibitor type 1 in the presence of calcium ion, and its
enhancement by heparin and vitronectin. Biochim Biophys Acta.
1298:199–208. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Urano T, Nagai N, Matsuura M, Ihara H,
Takada Y and Takada A: Human thrombin and calcium bound factor Xa
significantly shorten tPA-induced fibrin clot lysis time via
neutralization of plasminogen activator inhibitor type 1 activity.
Thromb Haemost. 80:161–166. 1998.PubMed/NCBI
|
|
27
|
Abou-Shady EA, Farrag HE, el-Damarawy NA,
Mohamed FA, Kamel AM and Massoud AA: In vitro effects of trace
elements on blood clotting and platelet function. A--Iron, copper,
and gold. J Egypt Public Health Assoc. 66:21–48. 1991.PubMed/NCBI
|
|
28
|
Rosenmund A, Haeberli A and Straub PW:
Blood coagulation and acute iron toxicity. Reversible iron-induced
inactivation of serine proteases in vitro. J Lab Clin Med.
103:524–533. 1984.PubMed/NCBI
|
|
29
|
Henriksson P, Nilsson L, Nilsson IM and
Stenberg P: Fatal iron intoxication with multiple coagulation
defects and degradation of factor VIII and factor XIII. Scand J
Haematol. 22:235–240. 1979. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Pretorius E and Lipinski B: Differences in
morphology of fibrin clots induced with thrombin and ferric ions
and its pathophysiological consequences. Heart Lung Circ.
22:447–449. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Orino K: Functional binding analysis of
human fibrinogen as an iron- and heme-binding protein. Biometals.
26:789–794. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Mishina M, Komaba Y, Kobayashi S, et al:
Administration of free radical scavenger edaravone associated with
higher frequency of hemorrhagic transformation in patients with
cardiogenic embolism. Neurol Med Chir (Tokyo). 48:292–297. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lipinski B, Pretorius E, Oberholzer HM and
Van Der Spuy WJ: Iron enhances generation of fibrin fibers in human
blood: implications for pathogenesis of stroke. Microsc Res Tech.
75:1185–1190. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Dempfle CE, Argiriou S, Alesci S, et al:
Fibrin formation and proteolysis during ancrod treatment. Evidence
for des-A-profibrin formation and thrombin independent factor XIII
activity. Ann NY Acad Sci. 936:210–214. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Drinane MC, Sherman JA, Hall AE, Simons M
and Mulligan-Kehoe MJ: Plasminogen and plasmin activity in patients
with coronary artery disease. J Thromb Haemost. 4:1288–1295. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Talbot K, Meixner SC and Pryzdial EL:
Enhanced fibrinolysis by proteolysed coagulation factor Xa. Biochim
Biophys Acta. 1804:723–730. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Xu X, Zhang L, Shen D, Wu H and Liu Q:
Oxygen-dependent oxidation of Fe(II) to Fe(III) and interaction of
Fe(III) with bovine serum albumin, leading to a hysteretic effect
on the fluorescence of bovine serum albumin. J Fluoresc.
18:193–201. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Davies MJ, Gilbert BC and Haywood RM:
Radical-induced damage to bovine serum albumin: role of the
cysteine residue. Free Radic Res Commun. 18:353–367. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zardeneta G, Milam SB and Schmitz JP:
Iron-dependent generation of free radicals: plausible mechanisms in
the progressive deterioration of the temporomandibular joint. J
Oral Maxillofac Surg. 58:302–308. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Crichton RR: Proteins of iron storage and
transport. Adv Protein Chem. 40:281–363. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Crichton RR and Charloteaux-Wauters M:
Iron transport and storage. Eur J Biochem. 164:485–506. 1987.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Tseng MT, Dozier A, Haribabu B and Graham
UM: Transendothelial migration of ferric ion in FeCl3
injured murine common carotid artery. Thromb Res. 118:275–280.
2006. View Article : Google Scholar : PubMed/NCBI
|
